TipRanks
Advertisement
Advertisement

DE:UG2 Stock Latest News

AngioDynamics announces Humana Medicare Advantage policy for NanoKnife
The FlyAngioDynamics announces Humana Medicare Advantage policy for NanoKnife
19h ago
ANGO
AngioDynamics price target lowered to $18 from $19 at H.C. Wainwright
PremiumThe Fly
AngioDynamics price target lowered to $18 from $19 at H.C. Wainwright
2d ago
ANGO
AngioDynamics Earnings Call Highlights MedTech-Fueled Momentum
PremiumCompany Announcements
AngioDynamics Earnings Call Highlights MedTech-Fueled Momentum
6d ago
ANGO
Morning Movers: Haemonetics up sharply after CSL Plasma supply pact
PremiumThe Fly
Morning Movers: Haemonetics up sharply after CSL Plasma supply pact
7d ago
HAE
PEP
AngioDynamics Names New CEO Amid Leadership Transition
PremiumCompany Announcements
AngioDynamics Names New CEO Amid Leadership Transition
7d ago
8K
ANGO
AngioDynamics Delivers Q1 2027 Growth, Confirms Outlook
PremiumCompany AnnouncementsAngioDynamics Delivers Q1 2027 Growth, Confirms Outlook
7d ago
8K
ANGO
AngioDynamics sees FY27 tariff impact ‘broadly similar’ to FY26
Premium
The Fly
AngioDynamics sees FY27 tariff impact ‘broadly similar’ to FY26
7d ago
ANGO
AngioDynamics sees FY27 adjusted EBITDA $13M-$16M
Premium
The Fly
AngioDynamics sees FY27 adjusted EBITDA $13M-$16M
7d ago
ANGO
AngioDynamics names Eric Honroth as CEO, succeeding Jim Clemmer
PremiumThe Fly
AngioDynamics names Eric Honroth as CEO, succeeding Jim Clemmer
7d ago
ANGO
AngioDynamics reports Q1 adjusted EPS (4c), consensus (11c)
PremiumThe Fly
AngioDynamics reports Q1 adjusted EPS (4c), consensus (11c)
7d ago
ANGO
AngioDynamics sees FY27 adjusted EPS (29c)-(24c), consensus (27c)
PremiumThe Fly
AngioDynamics sees FY27 adjusted EPS (29c)-(24c), consensus (27c)
7d ago
ANGO
Angiodynamics, Inc. (ANGO) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Angiodynamics, Inc. (ANGO) Q1 Earnings Cheat Sheet
9d ago
ANGO
AngioDynamics: Strong Med Tech Growth Outlook Supports Buy Rating and Maintained $20 Price Target
PremiumRatingsAngioDynamics: Strong Med Tech Growth Outlook Supports Buy Rating and Maintained $20 Price Target
2M ago
ANGO
AngioDynamics price target raised to $19 from $16 at H.C. Wainwright
Premium
The Fly
AngioDynamics price target raised to $19 from $16 at H.C. Wainwright
3M ago
ANGO
AngioDynamics price target raised to $20 from $16 at Canaccord
Premium
The Fly
AngioDynamics price target raised to $20 from $16 at Canaccord
3M ago
ANGO
AngioDynamics posts record Q4 and fiscal 2026 results
PremiumCompany Announcements
AngioDynamics posts record Q4 and fiscal 2026 results
3M ago
8K
ANGO
AngioDynamics Earnings Call Highlights Med Tech Surge
PremiumCompany Announcements
AngioDynamics Earnings Call Highlights Med Tech Surge
3M ago
ANGO
ANGO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ANGO Upcoming Earnings Report: What to Expect?
3M ago
ANGO
AngioDynamics receives FDA IDE approval for RELIEF feasibility study
PremiumThe Fly
AngioDynamics receives FDA IDE approval for RELIEF feasibility study
4M ago
ANGO
AngioDynamics announces two-year PRESERVE trial data
PremiumThe FlyAngioDynamics announces two-year PRESERVE trial data
5M ago
ANGO
AngioDynamics Files Patent Suit to Protect Thrombectomy Technology
Premium
Company Announcements
AngioDynamics Files Patent Suit to Protect Thrombectomy Technology
6M ago
8K
ANGO
AngioDynamics initiated with a Buy at Freedom Broker
Premium
The Fly
AngioDynamics initiated with a Buy at Freedom Broker
6M ago
ANGO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >